# COVID-19 on Placental Gene Expression and Pathology

> **NCT04585945** · — · COMPLETED · sponsor: **Prisma Health-Upstate** · enrollment: 68 (actual)

## Conditions studied

- COVID-19
- SARS-CoV-2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Positive for SARS-CoV-2 infection

## Key facts

- **NCT ID:** NCT04585945
- **Lead sponsor:** Prisma Health-Upstate
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-04
- **Primary completion:** 2021-04-21
- **Final completion:** 2022-02-28
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585945, "COVID-19 on Placental Gene Expression and Pathology". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04585945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*